These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2450237)

  • 21. Blood pressure and catecholamines following exercise during selective beta-blockade in hypertension.
    Vandongen R; Margetts B; Beilin LJ; deKlerk N; Rogers P
    Eur J Clin Pharmacol; 1986; 30(3):283-7. PubMed ID: 2874032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tertatolol potentiates exercise-induced atrial natriuretic peptide release by increasing atrial diameter in healthy subjects.
    Berlin I; Deray G; Lechat P; Maistre G; Landault C; Chermat V; Brouard R; Ressayre C; Puech AJ
    Cardiology; 1993; 83 Suppl 1():16-24. PubMed ID: 7903211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentration-effect and time-effect relationships of carteolol.
    Ishizaki T; Ohnishi A; Sasaki T; Chiba K; Suganuma T; Kushida K
    Eur J Clin Pharmacol; 1983; 25(6):749-57. PubMed ID: 6141053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of carteolol on silent myocardial ischemia, variability in heart rate, and the pain-modulating system.
    Takase B; Hikita H; Uehata A; Satomura K; Kurita A; Nakamura H
    Am Heart J; 1997 Nov; 134(5 Pt 1):945-54. PubMed ID: 9398108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of hepatic alpha- and beta-adrenergic receptor stimulation on hepatic glucose production during heavy exercise.
    Coker RH; Krishna MG; Lacy DB; Bracy DP; Wasserman DH
    Am J Physiol; 1997 Nov; 273(5):E831-8. PubMed ID: 9374667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women.
    Gullestad L; Hallen J; Medbø JI; Grønnerød O; Holme I; Sejersted OM
    Br J Clin Pharmacol; 1996 Jan; 41(1):57-67. PubMed ID: 8824694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of exercise-induced ST-segment depression in patients without typical angina pectoris.
    Sundkvist GM; Hjemdahl P; Kahan T; Melcher A
    J Intern Med; 2007 Feb; 261(2):148-58. PubMed ID: 17241180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of propranolol and pindolol on plasma ANP levels in humans at rest and during exercise.
    Bouissou P; Galen FX; Richalet JP; Lartigue M; Devaux F; Dubray C; Atlan G
    Am J Physiol; 1989 Aug; 257(2 Pt 2):R259-64. PubMed ID: 2527473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma catecholamines in exercise induced bronchoconstriction.
    Beil M; Brecht HM; Rasche B
    Klin Wochenschr; 1977 Jun; 55(12):577-81. PubMed ID: 18638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma norepinephrine, epinephrine, and dopamine beta-hydroxylase activity during exercise in man.
    Péronnet F; Cleroux J; Perrault H; Thibault G; Cousineau D; de Champlain J; Guilland JC; Klepping J
    Med Sci Sports Exerc; 1985 Dec; 17(6):683-8. PubMed ID: 4079740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of beta-adrenoceptor blockade on postexercise oxygen consumption and triglyceride/fatty acid cycling.
    Børsheim E; Bahr R; Høstmark AT; Knardahl S
    Metabolism; 1998 Apr; 47(4):439-48. PubMed ID: 9550543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproducibility of the catecholamine response to serial exercise testing in normals.
    Leavitt JA; Turner AK; Battinelli NJ; Coats MH; Falk RH
    Am J Med Sci; 1992 Mar; 303(3):160-4. PubMed ID: 1595777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-blocking effect of single oral doses of carteolol.
    Stoll RW; Cavanaugh JH; MacLeod CM
    Clin Pharmacol Ther; 1981 Nov; 30(5):605-10. PubMed ID: 7297020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenal and sympathetic catecholamines in exercising rats.
    Scheurink AJ; Steffens AB; Bouritius H; Dreteler GH; Bruntink R; Remie R; Zaagsma J
    Am J Physiol; 1989 Jan; 256(1 Pt 2):R155-60. PubMed ID: 2912208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-adrenergic blockade decreases norepinephrine release in humans.
    Rosen SG; Supiano MA; Perry TJ; Linares OA; Hogikyan RV; Smith MJ; Halter JB
    Am J Physiol; 1990 Jun; 258(6 Pt 1):E999-1005. PubMed ID: 2163203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postexercise peril. Plasma catecholamines and exercise.
    Dimsdale JE; Hartley LH; Guiney T; Ruskin JN; Greenblatt D
    JAMA; 1984 Feb; 251(5):630-2. PubMed ID: 6690837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cardioselective beta-blockade on plasma catecholamines and performance during different forms of exercise.
    Fikenzer S; Fikenzer K; Laufs U; Falz R; Schulze A; Busse M
    J Sports Med Phys Fitness; 2020 Apr; 60(4):643-649. PubMed ID: 31818057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catecholamine release and blood pressure changes induced by exercise in dogfish.
    Opdyke DF; Carroll RG; Keller NE
    Am J Physiol; 1982 Mar; 242(3):R306-10. PubMed ID: 7065227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of mental and physical stress on plasma catecholamine levels before and after beta-adrenoceptor blocker treatment.
    Paran E; Neumann L; Cristal N
    Eur J Clin Pharmacol; 1992; 43(1):11-5. PubMed ID: 1354617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma catecholamines and heart rate at the beginning of muscular exercise in man.
    Orizio C; Perini R; Comandè A; Castellano M; Beschi M; Veicsteinas A
    Eur J Appl Physiol Occup Physiol; 1988; 57(5):644-51. PubMed ID: 3396585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.